Evidence map›Paper›PMID 32691890›Full record

ArticleJournal of medical virology2021

ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.

Laura Torre-Fuentes, Jorge Matías-Guiu, Laura Hernández-Lorenzo, Paloma Montero-Escribano, Vanesa Pytel, Jesús Porta-Etessam, Ulises Gómez-Pinedo, Jordi A Matías-Guiu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 7 pooled it
2.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 7 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Frontiers in genetics · 2022
    Pooled it
  7. Pooled it
  8. Article
  9. Review
  10. Genetic variants inFrontiers in genetics · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Role ofAfrican journal of laboratory medicine · 2024
    Article
  17. Article
  18. Article
  19. The immunogenetics of COVID-19.Immunogenetics · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Laura Torre-FuentesDepartment of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.
Jorge Matías-GuiuDepartment of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.
Laura Hernández-LorenzoDepartment of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.
Paloma Montero-EscribanoDepartment of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.
Vanesa PytelDepartment of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.
Jesús Porta-EtessamDepartment of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.
Ulises Gómez-PinedoDepartment of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.ORCID 0000-0003-3097-5557
Jordi A Matías-GuiuDepartment of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.ORCID 0000-0001-5520-2708
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been suggested that some individuals may present genetic susceptibility to SARS-CoV-2 infection, with particular research interest in variants of the ACE2 and TMPRSS2 genes, involved in viral penetration into cells, in different populations and geographic regions, although insufficient information is currently available. This study addresses the apparently reasonable hypothesis that variants of these genes may modulate viral infectivity, making some individuals more vulnerable than others. Through whole-exome sequencing, the frequency of exonic variants of the ACE2, TMPRSS2, and Furin genes was analyzed in relation to presence or absence of SARS-CoV-2 infection in a familial multiple sclerosis cohort including 120 individuals from Madrid. The ACE2 gene showed a low level of polymorphism, and none variant was significantly associated with SARS-CoV-2 infection. These variants have previously been detected in Italy. While TMPRSS2 is highly polymorphic, the variants found do not coincide with those described in other studies, with the exception of rs75603675, which may be associated with SARS-CoV-2 infection. The synonymous variants rs61735792 and rs61735794 showed a significant association with infection. Despite the limited number of patients with SARS-CoV-2 infection, some variants, especially in TMPRSS2, may be associated with COVID-19.

Indexed as

Angiotensin-Converting Enzyme 2Cohort StudiesCOVID-19Exome SequencingFurinGene ExpressionGenetic Predisposition to DiseaseHost-Pathogen InteractionsHumansMultiple SclerosisPolymorphism, GeneticProtein BindingReceptors, VirusSARS-CoV-2Serine EndopeptidasesSpainACE2 protein, humanAngiotensin-Converting Enzyme 2FurinFURIN protein, humanReceptors, VirusSerine EndopeptidasesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2TMPRSS2 protein, humanACE2coronavirusCOVID-19familial multiple sclerosisSARS-CoV-2SpainTMPRSS2whole-exome sequencing

Identifiers

PMID32691890
PMCPMC7404937
OpenAlexW3044263164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.